BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2011
View Archived Issues
Phase I trial assesses new ruthenium-based anticancer agent NKP-1339 in advanced solid tumors
Read More
Phase I data on MLN-4924 in solid tumors suggest antitumor activity
Read More
Phase I data on liposomal docetaxel formulation ATI-1123 encourage further clinical study
Read More
ALXN-4100TPO counteracts effects of radiation by inducing hematopoietic recovery in vivo
Read More
New histamine H3 receptor antagonists presented by Servier
Read More
Scientists at Novartis present novel MEK inhibitors
Read More
PCI Biotech reports on phase I/II trial of Amphinex/bleomycin combination PC-A11
Read More
OCID-2987 is active in models of asthma and COPD
Read More
Reduced mGluR5 levels in brain may be biomarker for neurodegeneration in mild cognitive impairment
Read More
Almirall and Forest Laboratories report U.S. submission of NDA for aclidinium bromide in COPD
Read More
Immune Pharmaceuticals licenses bertilimumab from iCo Therapeutics
Read More
Sanofi and Weill Cornell Medical College join to discover new tuberculosis therapies
Read More
Basilea Pharmaceutica's BAL-101553 advances to clinic to treat solid tumors
Read More
Novartis' phase III GLOW2 trial of NVA-237 in COPD meets primary endpoint
Read More
Polyphor claims new beta-hairpin peptidomimetic chemokine CXCR4 receptor antagonists
Read More
Roche patents novel monoamine reuptake inhibitors
Read More
Novel bile acid GPBA receptor agonists reported by Exelexis
Read More
CHMP adopts positive opinion on new Kiovig indication in multifocal motor neuropathy
Read More
Zalicus begins phase IIb trial of Synavive in rheumatoid arthritis
Read More
Promising preliminary phase IIb data on Anacor's AN-2728 in psoriasis
Read More
Vivus seeks approval in U.S. of avanafil for erectile dysfunction
Read More
GW Pharmaceuticals starts second phase III Sativex trial
Read More
Lux Biosciences to appeal CHMP's negative opinion on Luveniq for noninfectious uveitis
Read More
BioLineRx signs license agreement with Yissum Research Development for BL-7040
Read More
Alkermes reports promising topline results from phase Ib ALKS-9070 trial in schizophrenia
Read More
Viibryd launched in U.S. for treatment of major depressive disorder
Read More